On April 27th 2023 the steering committee of the SWITCH trial discussed the progress of the trial after randomisation of more than 200 patients. After a careful evaluation of the funding resources and the recruitment rate, the steering committee decided to stop the trial due to “lack of further funding” […]

Stop of the trial

The trial team of the Centre Hospitalier Universitaire de Caen included their first patient in the randomized trial. This patient is also the first French patient enrolled in SWITCH. Congratulations to the team for their effort!

First patient in France!